IL32 and breast cancer: We demonstrate that activated human T cells predominantly express and secrete the IL-32β protein isoform and reveal CD4+ T cells as the main IL-32β producers in blood of healthy individuals, while in primary tumors of breast cancer patients Treg and Th1 Teff represent the major IL-32 producing subsets.